Delivery Order SPE2DB22D1017-SPE2DB25FYRCM
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,360.04 to AmerisourceBergen Drug Corp for the supply of Ambien CR 6.25 mg tablets (100-count units) on September 5, 2025, with an ultimate completion date of September 8, 2025. This competitive award utilizes firm fixed pricing and carries no set-aside designation. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, the company's headquarters and a major distribution hub for...
- The Defense Logistics Agency has awarded a delivery order valued at $3,232.63 to AmerisourceBergen Drug Corp for the supply of Ambien CR 6.25 mg tablets in quantities of 100 units. This competitively awarded contract, issued on September 9, 2025, with an ultimate completion date of September 10, 2025, represents a firm fixed-price delivery order with no set-aside designation. The pharmaceutical products will be delivered to AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $4,118.84 delivery order to AmerisourceBergen Drug Corp for 100 tablets of Ambien CR 6.25 mg on July 22, 2025, with ultimate completion scheduled for July 23, 2025. This contract utilizes firm fixed pricing and carries no set-aside designation, reflecting a competitively awarded transaction. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting...
- The Defense Logistics Agency awarded a delivery order valued at approximately $4,979 to AmerisourceBergen Drug Corp for 100 tablets of Ambien CR 6.25 mg. This is a firm fixed-price, non-set-aside contract with a completion date of September 3, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs for military and veteran healthcare systems. The delivery order represents a child contract under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,441.94 to AmerisourceBergen Drug Corp for the supply of Ambien CR 6.25 mg tablets (100-count packages) on August 27, 2025, with an ultimate completion date of August 28, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,890.69 to AmerisourceBergen Drug Corp for the supply of Ambien CR 6.25 mg tablets (100-count units) on August 27, 2025, with an ultimate completion date of August 28, 2025. This competitive award, issued under firm fixed pricing with no set-aside designation, represents a continuation of the company's pharmaceutical supply services to federal medical procurement needs. The place of performance is AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,640.38 to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Ambien CR 6.25 mg tablets in quantities of 100 units. This non-competitive, firm fixed-price delivery order is set to be completed by September 5, 2025, and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting federal medical supply...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ambien CR 6.25 mg tablets (100-count units) under a firm fixed price contract valued at $2,770.27. The order was competitively awarded without set-aside designation and carries an ultimate completion date of July 15, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform all work at its corporate office location. This delivery order is a child contract issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,610.42 to AmerisourceBergen Drug Corp for Ambien CR 6.25 mg tablets (100-count units), with an ultimate completion date of September 15, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's broader pharmaceutical supply relationship with DLA. The awardee, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $15,429.77 to AmerisourceBergen Drug Corp for the supply of Ambien CR 6.25 mg tablets (100-count units). This non-competitive, firm fixed-price delivery order was issued on July 22, 2025, with an ultimate completion date of July 23, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FYRCMDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,070.69 to AmerisourceBergen Drug Corp for the supply of Ambien CR 6.25 mg tablets (100 count) under a firm fixed-price contract. The award, issued on September 17, 2025, with completion targeted for September 18, 2025, was made through open competition with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its Corporate Office location. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999.00 ceiling value through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, serving customers including the Defense Health Agency and U.S. Coast Guard. The company's consistent performance on such contracts demonstrates its capability to fulfill federal medical procurement requirements across multiple therapeutic domains through competitively awarded delivery orders.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.1k | 9/17/25 |